Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b randomized double-blind single-dose active-controlled study of MEDI8852 in hospitalized adults with influenza A
2015-004276-29Phase 2Terminated
- Sponsor
- MedImmune
- Start
- Aug 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Influenza A infection comparing MEDI8852 + standard of care with Active control + standard of care (2 arms). Primary endpoint: Time to normalization of respiratory function. Started Aug 2016; status: terminated.
02
Drugs
MEDI8852
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on 2015-004276-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004276-29.